On Monday, Oncolytics Biotech, Inc (NASDAQ: ONCY) was -4.78% drop from the session before settling in for the closing price of $0.99. A 52-week range for ONCY has been $0.33 – $1.51.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 23.13%. When this article was written, the company’s average yearly earnings per share was at 10.34%. With a float of $98.63 million, this company’s outstanding shares have now reached $103.64 million.
Oncolytics Biotech, Inc (ONCY) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Oncolytics Biotech, Inc stocks. The insider ownership of Oncolytics Biotech, Inc is 1.72%, while institutional ownership is 2.81%.
Oncolytics Biotech, Inc (ONCY) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.1 earnings per share (EPS) during the time that was better than consensus figure (set at -0.13) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 10.34% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.45% during the next five years compared to 23.13% growth over the previous five years of trading.
Oncolytics Biotech, Inc (NASDAQ: ONCY) Trading Performance Indicators
You can see what Oncolytics Biotech, Inc (ONCY) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.84.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.28, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.24 in one year’s time.
Technical Analysis of Oncolytics Biotech, Inc (ONCY)
The latest stats from [Oncolytics Biotech, Inc, ONCY] show that its last 5-days average volume of 0.83 million was inferior to 0.99 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 58.91%.
During the past 100 days, Oncolytics Biotech, Inc’s (ONCY) raw stochastic average was set at 20.38%, which indicates a significant decrease from 41.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0625 in the past 14 days, which was lower than the 0.0851 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1300, while its 200-day Moving Average is $0.8752. Now, the first resistance to watch is $0.9831. This is followed by the second major resistance level at $1.0215. The third major resistance level sits at $1.0430. If the price goes on to break the first support level at $0.9232, it is likely to go to the next support level at $0.9017. Assuming the price breaks the second support level, the third support level stands at $0.8633.
Oncolytics Biotech, Inc (NASDAQ: ONCY) Key Stats
There are 100,361K outstanding shares of the company, which has a market capitalization of 100.28 million. As of now, sales total 0 K while income totals -23,140 K. Its latest quarter income was 0 K while its last quarter net income were -10,450 K.
